The University of Szeged (SZTE) is setting a national benchmark for innovative medical practices, particularly in cancer treatment. According to a statement from the university’s public relations department, its focus on interventional oncology is revolutionizing how cancer is managed in Hungary.
Interventional oncology, a specialized branch of interventional radiology, is a relatively young discipline that leverages advanced imaging technologies such as ultrasound, CT, and MRI to perform minimally invasive procedures. While these techniques are widely used abroad, their application in Hungary remains limited.
At SZTE, one such method, electrochemotherapy, has been in use for years. This procedure employs electrical impulses to enhance the precision and effectiveness of cancer treatments, offering a less invasive option for patients.
Dean of SZTE’s Albert Szent-Györgyi Medical School György Lázár emphasized that interventional radiology is becoming increasingly prominent in global oncology. Recognizing this trend, SZTE is committed to expanding the development and application of interventional oncology, which Lázár describes as a cornerstone of future cancer care.
‘It is essential to integrate these methods into medical education in Szeged,’ Lázár stated. He also highlighted the scarcity of skilled professionals in Hungary capable of performing these advanced procedures. By aiming to become a national hub for interventional oncology, SZTE seeks to bridge this gap.
This mission is supported by SZTE alumnus Béla Kis, now head of the specialized interventional radiology department at the Moffitt Cancer Center in Tampa, Florida. Kis has offered his expertise to SZTE, contributing to the training of Szeged’s medical professionals and facilitating telemedicine consultations. His involvement strengthens SZTE’s national and international reputation.
Head of the Oncotherapy Clinic at SZTE Judit Oláh stressed that modern cancer care goes beyond prolonging survival. The focus is increasingly on improving patients’ quality of life. ‘For many, maintaining independence and self-sufficiency is more important than merely extending life expectancy,’ Oláh noted.
SZTE aims to involve patients and their families more closely in treatment decisions, tailoring care to individual goals and risks. By prioritizing gentler treatments with fewer side effects, SZTE is committed to enhancing the quality of life for patients during their cancer journey.
As Szeged University continues to push the boundaries of interventional oncology, it serves as a model for integrating innovative medical practices with patient-centred care. Through collaboration, education, and cutting-edge treatments, SZTE is poised to lead Hungary into a new era of cancer care.
Related articles:
